Johnson & Johnson CEDEAR | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
13,831
16,323
15,409
16,540
1,300
Depreciation, Depletion & Amortization
4,104
3,895
3,746
3,754
5,642
Other Funds
56
-
57
15
188
Funds from Operations
18,355
19,537
17,940
20,540
9,815
Changes in Working Capital
941
1,066
1,339
1,773
11,241
Net Operating Cash Flow
17,414
18,471
19,279
18,767
21,056
Capital Expenditures
3,595
3,714
3,463
3,226
3,279
Sale of Fixed Assets & Businesses
458
4,631
3,464
1,267
1,832
Purchase/Sale of Investments
865
10,794
6,679
1,830
21,964
Net Investing Cash Flow
5,103
12,305
7,735
4,761
14,868
Cash Dividends Paid - Total
7,286
7,768
8,173
8,621
8,943
Issuance/Reduction of Debt, Net
2,028
850
1,379
7,875
6,754
Net Financing Cash Flow
6,091
12,260
10,846
8,551
7,673
Net Change in Cash
6,016
6,404
791
5,240
1,148
Free Cash Flow
13,819
14,757
15,816
15,541
17,777
Deferred Taxes & Investment Tax Credit
607
441
270
341
2,406
Net Assets from Acquisitions
835
2,129
954
4,509
35,151
Change in Capital Stock
889
5,342
3,995
7,790
5,296
Exchange Rate Effect
204
310
1,489
215
337
Other Uses
266
299
103
123
234
About Johnson & Johnson CEDEAR
View Profile
